FORMULATION AND EVALUATION OF ACYCLOVIR LOADED NOVEL NANO-EMULSION GEL FOR TOPICAL TREATMENT OF HERPES SIMPLEX VIRAL INFECTIONS
Acyclovir has low bioavailability mainly due to low solubility. This study aimed to formulate an optimized acyclovir (ACV) nanoemulsion gel for the slow, variable and incomplete oral drug absorption in patient suffering from herpes simplex viral infection. The dispersion solubility of acyclovir was studied in various oils, surfactants and co-surfactants and by constructing pseudo phase ternary diagram nanoemulsion area was identified. The optimized formulations of nanoemulsions were subjected to thermodynamic stability tests. After stability study, stable formulation was characterized for droplet size, pH determination, centrifugation, % drug content in nanoemulsion, Zeta Potential and Vesicle size measurement and than nanoemulsion gel were prepared and characterized for spreadability, measurement of viscosity, drug content, In-vitro diffusion, in-vitro release data. Span 40 was selected as surfactant, PEG 400 as co surfactant and castor oil as oil component based on solubility study. The in vitro drug release from acyclovir nanoemulsion gel was found to be considerably higher in comparison to that of the pure drug. The in-vitro diffusion of nanoemulsion gel was significantly good. Based on this study, it can be concluded the solubility and permeability of acyclovir can be increased by formulating into nanoemulsion gel.
Keywords: Acyclovir, Nanoemulsion, In-vitro diffusion, Zeta potential, Stability
2. Uchoa UB, Rezende RA, Carrasco MA, Rapuano CJ, Laibson PR, Cohen EJ. Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection, Archives of Ophthalmology, 2003; 121:1702-1704.
3. Kristl A, Srcic S, Vrecer F, Sustar B, Vojnovic D. Polymorphism and pseudopolymorphism: influencing the dissolution properties of the guanine derivative acyclovir International Journal of Pharmaceutics, 1996; 139:231-235.
4. Von Plessing Rossel C, Carreño JS, Rodríguez-Baeza M, Alderete JB. Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phase, Química Nova, 2000; 23:749-752.
5. De Clercq E. Antivirals for the treatment of herpesvirus infections, Journal of Antimicrobial Chemotherapy, 1993; 32 Suppl A:121-132.
6. Shah P, Bhalodia D, Shelat P. Nanoemulsions, a pharmaceutical review, Systematic Reviews in Pharmacy, 2010; 1(1):24.
7. Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates-a review, Journal of Control Release. 2008; 12:185-199.
8. Forster T. Principles of emulsion formation. In: Rieger MM, Rhein LD, editors. Surfactants in Cosmetics. 2nd ed. New York, NY, USA: Marcel Dekker Inc; 1997.
9. Ravi TPU, Padma T. Nano emulsions for drug delivery through different routes, Biotechnology Research, 2011; 2(3):1-13.
10. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems, Advanced Drug Delivery Reviews, 2000; 45:89-121.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).